Table of Contents
Volume 2 | Issue 2
Publication Date: November 2000- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
90 |
Locally Advanced, Unresectable Non–Small-Cell Lung Cancer Shift in the Treatment Paradigm Chandra P. Belani |
|
Meeting Highlights | ||
93-96 |
Highlights from: 9th World Conference on Lung Cancer, Tokyo, Japan Amy D‘Orazio |
|
Research in Brief | ||
97-98 |
Phase III Trials Concurrent Chemotherapy and Radiation Therapy: A New Standard of Care for Stage III Non–Small-Cell Lung Cancer? CIG Media Group |
|
Comprehensive Review | ||
101-110 |
Image-Guided Fine Needle Aspirate Strategies for Staging of Lung Cancer Clare Savage, Joseph B. Zwischenberger |
|
Commentary | ||
111-112 |
Commentary on “Image-Guided Fine Needle Aspirate Strategies for Staging of Lung Cancer” Douglas E. Wood |
|
Comprehensive Reviews | ||
116-120 |
Lymph Node Micrometastases in Non–Small-Cell Lung Cancer: Clinical Applications Jorge H. Perez-Cardona, Nelson G. Ordonez, Frank V. Fossella |
|
123-127 |
Vinorelbine and Gemcitabine Combinations in Advanced Non–Small-Cell Lung Cancer Rogerio C. Lilenbaum, Roy S. Herbst |
|
Original Contributions | ||
128-132 |
A Phase I Study of STEALTH® Cisplatin (SPI-77) and Vinorelbine in Patients with Advanced Non–Small-Cell Lung Cancer Everett E. Vokes, Gary S. Gordon, Ann M. Mauer, Charles M. Rudin, Stuart A. Krauss, Livia Szeto, Harvey M. Golomb, Philip C. Hoffman |
|
133-138 |
Second-Line Gemcitabine in Refractory Stage IV Non–Small-Cell Lung Cancer: A Phase II Trial Heidi H. Gillenwater, Maureen Tynan, Susan Natoli, Michael J. Schell, Mark A. Socinski |
|
Translational Medicine | ||
141-145 |
Fragile Histidine Triad (FHIT) Gene Abnormalities in Lung Cancer Sabine Zöchbauer-Müller, Ignacio I. Wistuba, John D. Minna, Adi F. Gazdar |
|
Imaging in Lung Cancer | ||
146-150 |
Treatment Outcome of Lung Cancer Patients as Optimized by Preoperative Whole-Body Positron Emission Tomography Fluorodeoxyglucose Imaging Naresh C. Gupta, Harry A. Bishop, John S. Rogers, Wael Z. Tamim, Shawn D. Reesman |
|
Commentary | ||
151 |
Commentary on “Treatment Outcome of Lung Cancer Patients as Optimized by Preoperative Whole-Body Positron Emission Tomograpy Fluorodeoxyglucose Imaging” Abass Alavi |
|
Letter to the Editor | ||
152 |
Letter to the editor Robert O. Dillman |
|